An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2

The prevailing pandemic of SARS-CoV-2 highlights the desperate need of alternative vaccine-platforms, which are safe, effective, and can be modified to carry antigens of emerging pathogens. The current SARS-CoV-2 vaccines based on mRNA and adenoviral vector technology meet some of these criteria but...

Full description

Saved in:
Bibliographic Details
Main Authors: Himadri B. Thapa, Anna M. Müller, Andrew Camilli, Stefan Schild
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
RBD
Online Access:https://doaj.org/article/f3db165878514641bd9bcc7d26aa6cf4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items